Arash Keyhani, DO
Vascular Surgery · Houston, TXNPI 1770760522
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (34.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Medtronic at 50.6% of the total. Reporting peaked in 2019 at $13,534 and has fallen 77.6% since, to $3,037 in 2025.
Across 242 payments — averaging $152.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$19K
- Boston Scientific$4K
- W. L. Gore & Associates, Inc.$4K
- Integra Lifesciences Corporation$2K
- Silk Road Medical, Inc.$2K
- Inari Medical, Inc.$2K
- plus $4K from 23 others
What the payments were for
- Speaking & faculty fees$10,85029%
- Travel & lodging$11,29031%
- Food & beverage$12,76134%
- Education$380%
- Other$2,0676%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 73 | $18,717 |
| Boston Scientific | 7 | $4,195 |
| W. L. Gore & Associates, Inc. | 54 | $4,098 |
| Integra Lifesciences Corporation | 2 | $2,092 |
| Silk Road Medical, Inc. | 12 | $1,802 |
| Inari Medical, Inc. | 11 | $1,671 |
| Angiodynamics, Inc. | 20 | $802 |
| Imperative Care, Inc | 15 | $779 |
| Cook Medical LLC | 6 | $626 |
| Penumbra, Inc. | 2 | $271 |
| Bolton Medical Inc | 2 | $270 |
| Abiomed | 2 | $260 |
| Limflow Inc. | 1 | $225 |
| Tactile Systems Technology Inc | 15 | $222 |
| Bard Peripheral Vascular, Inc. | 4 | $188 |
| Endologix LLC | 1 | $130 |
| Smith+Nephew | 1 | $117 |
| AbbVie | 1 | $97 |
| Philips North America LLC | 1 | $90 |
| Shockwave Medical, Inc | 1 | $75 |
| Edwards Lifesciences | 2 | $70 |
| Kerecis Limited | 2 | $53 |
| Urgo Medical North America, LLC | 1 | $33 |
| Biom'up France SAS | 1 | $32 |
| Medistim USA, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $20 |
| Lemaitre Vascular, Inc. | 1 | $19 |
| Merck | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HawkOne$7,987
- IN.PACT Admiral$7,406
- JETSTREAM$3,750
- ACell$2,067
- ENROUTE Transcarotid Neuroprotection System$1,924
- ENROUTE Transcarotid Stent$1,625
- CT THROMBECTOMY SYSTEM KIT$1,278
- FLOWTRIEVER CATHETER, S$1,278
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$985
- ENHANCE Transcarotid Peripheral Access Kit$935
- ENROUTE .014 Guidewire$935
- GORE TAG Thoracic Branch Endoprosthesis$816
- SYMPHONY CATHETER$530
- VenaSeal$392
- Endurant$380
- Auryon Laser System 100-120 Vac$333
- GORE VIABAHN VBX Balloon Expandable Endo$330
- Valiant Navion$321
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$299
- Indigo System$271
How this compares
$37,006 in reported general payments places this provider in the 80th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $6,842 |
| ClopidogrelClopidogrel Bisulfate | 63 | $672 |
| Silver Sulfadiazine | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Houston
- Alan LumsdenHouston$742K
- Gustavo OderichHouston$319K
- Jean BismuthHouston$243K
- Ali AzizzadehHouston$181K
- Steven MaximusHouston$140K
- Samuel LeonardHouston$96K
- Charudatta BavareHouston$72K
- Philip AuyangHouston$43K
- Jayer ChungHouston$42K
- Rana AfifiHouston$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.